Pangaea Oncology, S.A. (BME:PANG)

Spain · Delayed Price · Currency is EUR

1.700

-0.060 (-3.53%)

Apr 7, 2026, 4:00 PM CET

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Biotechnology	9.95M	6.68M	6.71M	6.18M	5.50M
Biotechnology Growth	49.12%	-0.48%	8.61%	12.20%	-3.10%
Total	9.95M	6.68M	6.71M	6.18M	5.50M
Total Growth	49.12%	-0.48%	8.61%	12.20%	-3.10%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Spain	7.02M	3.81M	3.22M	3.37M	2.57M
Spain Growth	84.22%	18.14%	-4.35%	31.16%	10.84%
Other Countries of The European Union	219.59K	100.66K	689.76K	365.18K	686.75K
Other Countries of The European Union Growth	118.15%	-85.41%	88.89%	-46.83%	-6.63%
Other	763.25K	458.91K	690.01K	-	60.23K
Other Growth	66.32%	-33.49%	-	-	1216.99%
United States	-	-	-	364.36K	-
Total	8.00M	4.37M	4.60M	4.10M	3.32M
Total Growth	83.12%	-5.11%	12.29%	23.61%	8.44%

Source: S&P Global Market Intelligence.